A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

被引:154
作者
Vinereanu, Dragos [1 ]
Lopes, Renato D. [2 ,3 ,4 ]
Cecilia Bahit, M. [5 ,6 ]
Xavier, Denis [7 ]
Jiang, Jie [8 ]
Al-Khalidi, Hussein R. [2 ]
He, Wensheng [2 ]
Xian, Ying [2 ,9 ]
Ciobanu, Andrea O. [1 ]
Kamath, Deepak Y. [7 ]
Fox, Kathleen A. [2 ]
Rao, Meena P. [2 ]
Pokorney, Sean D. [2 ]
Berwanger, Otavio [4 ,10 ]
Tajer, Carlos [11 ]
de Barros e Silva, Pedro G. M. [4 ,10 ]
Roettig, Mayme L. [2 ]
Huo, Yong [8 ]
Granger, Christopher B. [2 ]
机构
[1] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp, Bucharest, Romania
[2] Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
[4] BCRI, Sao Paulo, Brazil
[5] INECO Neurociencias, Rosario, Santa Fe, Argentina
[6] ACRG, Rosario, Santa Fe, Argentina
[7] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India
[8] Peking Univ, Hosp 1, Beijing, Peoples R China
[9] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27705 USA
[10] Hosp Coracao, Heart Hosp, Res Inst HCor, Sao Paulo, SP, Brazil
[11] Hosp El Cruce, Buenos Aires, DF, Argentina
关键词
ANTITHROMBOTIC TREATMENT; REGIONAL DIFFERENCES; STROKE; THERAPY; PREVENTION; KNOWLEDGE; REGISTRY;
D O I
10.1016/S0140-6736(17)32165-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the impact of a multifaceted educational intervention, versus usual care, on oral anticoagulant use in patients with atrial fibrillation. Methods This study was a two-arm, prospective, international, cluster-randomised, controlled trial. Patients were included who had atrial fibrillation and an indication for oral anticoagulation. Clusters were randomised (1:1) to receive a quality improvement educational intervention (intervention group) or usual care (control group). Randomisation was carried out centrally, using the eClinicalOS electronic data capture system. The intervention involved education of providers and patients, with regular monitoring and feedback. The primary outcome was the change in the proportion of patients treated with oral anticoagulants from baseline assessment to evaluation at 1 year. The trial is registered at ClinicalTrials. gov, number NCT02082548. Findings 2281 patients from five countries (Argentina, n=343; Brazil, n=360; China, n=586; India, n=493; and Romania, n=499) were enrolled from 48 clusters between June 11, 2014, and Nov 13, 2016. Follow-up was at a median of 12.0 months (IQR 11.8-12.2). Oral anticoagulant use increased in the intervention group from 68% (804 of 1184 patients) at baseline to 80% (943 of 1184 patients) at 1 year (difference 12%), whereas in the control group it increased from 64% (703 of 1092 patients) at baseline to 67% (732 of 1092 patients) at 1 year (difference 3%). Absolute difference in the change between groups was 9.1% (95% CI 3.8-14.4); odds ratio of change in the use of oral anticoagulation between groups was 3.28 (95% CI 1.67-6.44; adjusted p value=0.0002). Kaplan-Meier estimates showed a reduction in the secondary outcome of stroke in the intervention versus control groups (HR 0.48, 95% CI 0.23-0.99; log-rank p value=0.0434). Interpretation A multifaceted and multilevel educational intervention, aimed to improve use of oral anticoagulation in patients with atrial fibrillation and at risk for stroke, resulted in a significant increase in the proportion of patients treated with oral anticoagulants. Such an intervention has the potential to improve stroke prevention around the world for patients with atrial fibrillation.
引用
收藏
页码:1737 / 1746
页数:10
相关论文
共 30 条
  • [1] Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association
    Amara, Walid
    Larsen, Torben B.
    Sciaraffia, Elena
    Hernandez Madrid, Antonio
    Chen, Jian
    Estner, Heidi
    Todd, Derick
    Bongiorni, Maria G.
    Potpara, Tatjana S.
    Dagres, Nikolaos
    Sagnol, Pascal
    Blomstrom-Lundqvist, Carina
    [J]. EUROPACE, 2016, 18 (01): : 151 - 155
  • [2] Effect of a Multifaceted Intervention on Use of Evidence-Based Therapies in Patients With Acute Coronary Syndromes in Brazil The BRIDGE-ACS Randomized Trial
    Berwanger, Otavio
    Guimaraes, Helio P.
    Laranjeira, Ligia N.
    Cavalcanti, Alexandre B.
    Kodama, Alessandra A.
    Zazula, Ana Denise
    Santucci, Eliana V.
    Victor, Elivane
    Tenuta, Marcos
    Carvalho, Vitor
    Mira, Vera Lucia
    Pieper, Karen S.
    Weber, Bernardete
    Mota, Luiz Henrique
    Peterson, Eric D.
    Lopes, Renato D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (19): : 2041 - 2049
  • [3] Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
    Camm, A. John
    Accetta, Gabriele
    Ambrosio, Giuseppe
    Atar, Dan
    Bassand, Jean-Pierre
    Berge, Eivind
    Cools, Frank
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Kayani, Gloria
    Koretsune, Yukihiro
    Mantovani, Lorenzo G.
    Misselwitz, Frank
    Oh, Seil
    Turpie, Alexander G. G.
    Verheugt, Freek W. A.
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Corbalan, Ramon
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Darius, Harald
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Ten Cate, Hugo
    Atar, Dan
    Stepinska, Janina
    Panchenko, Elizaveta
    Lim, Toon Wei
    Jacobson, Barry
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    [J]. HEART, 2017, 103 (04) : 307 - 314
  • [4] Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
    Chugh, Sumeet S.
    Havmoeller, Rasmus
    Narayanan, Kumar
    Singh, David
    Rienstra, Michiel
    Benjamin, Emelia J.
    Gillum, Richard F.
    Kim, Young-Hoon
    McAnulty, John H.
    Zheng, Zhi-Jie
    Forouzanfar, Mohammad H.
    Naghavi, Mohsen
    Mensah, George A.
    Ezzati, Majid
    Murray, Christopher J. L.
    [J]. CIRCULATION, 2014, 129 (08) : 837 - 847
  • [5] Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
    Clarkesmith, Danielle E.
    Pattison, Helen M.
    Khaing, Phyo H.
    Lane, Deirdre A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
  • [6] Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
    Clarkesmith, Danielle E.
    Pattison, Helen M.
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    [J]. PLOS ONE, 2013, 8 (09):
  • [7] Donner A., 2000, DESIGN ANAL CLUSTER
  • [8] TEST STATISTICS AND SAMPLE-SIZE FORMULAS FOR COMPARATIVE BINOMIAL TRIALS WITH NULL HYPOTHESIS OF NONZERO RISK DIFFERENCE OR NON-UNITY RELATIVE RISK
    FARRINGTON, CP
    MANNING, G
    [J]. STATISTICS IN MEDICINE, 1990, 9 (12) : 1447 - 1454
  • [9] HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement
    Frankel, David S.
    Parker, Sarah E.
    Rosenfeld, Lynda E.
    Gorelick, Philip B.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08) : 1691 - 1700
  • [10] Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
    Gladstone, David J.
    Bui, Esther
    Fang, Jiming
    Laupacis, Andreas
    Lindsay, M. Patrice
    Tu, Jack V.
    Silver, Frank L.
    Kapral, Moira K.
    [J]. STROKE, 2009, 40 (01) : 235 - 240